Volume 118, Issue 12 | Journal of Neural Transmission

Journal of Neural Transmission

Translational Neuroscience, Neurology and Preclinical Neurological Studies, Psychiatry and Preclinical Psychiatric Studies

Publishing model:: Hybrid

Submit your manuscript

Search all Journal of Neural Transmission articles

Volume 118, Issue 12

December 2011

Special issue: L-Dopa-associated motor complications

Issue Editors:

Manfred Gerlach,
Peter Riederer,
Dieter Scheller

7 articles in this issue

Mechanisms underlying and medical management of l-Dopa-associated motor complications
Manfred Gerlach
Peter Riederer
Dieter Scheller
Editorial 11 November 2011 Pages: 1659 - 1660
Mechanisms underlying the onset and expression of levodopa-induced dyskinesia and their pharmacological manipulation
Mahmoud M. Iravani
Peter Jenner
Basic Neurosciences, Genetics and Immunology - Review article 01 September 2011 Pages: 1661 - 1690
Continuous drug delivery in early- and late-stage Parkinson’s disease as a strategy for avoiding dyskinesia induction and expression
P. Jenner
A. C. McCreary
D. K. A. Scheller
Movement Disorders - Review article 01 September 2011 Pages: 1691 - 1702
Pharmacological characterization of MRZ-8676, a novel negative allosteric modulator of subtype 5 metabotropic glutamate receptors (mGluR5): focus on l-DOPA-induced dyskinesia
Andrzej Dekundy
Andreas Gravius
Wojciech Danysz
Basic Neurosciences, Genetics and Immunology - Original Article 16 December 2010 Pages: 1703 - 1716
Transcriptional alterations under continuous or pulsatile dopaminergic treatment in dyskinetic rats
E. Grünblatt
W. J. Schmidt
M. Gerlach
Movement Disorders - Original Article 25 December 2010 Pages: 1717 - 1725
Flibanserin attenuates l-DOPA-sensitized contraversive circling in the unilaterally 6-hydroxydopamine-lesioned rat model of Parkinson’s disease
Manfred Gerlach
Jürgen Beck
Maarten van den Buuse
OriginalPaper 28 January 2011 Pages: 1727 - 1732
Role of dopamine D₃ and serotonin 5-HT_1A receptors in l-DOPA-induced dyskinesias and effects of sarizotan in the 6-hydroxydopamine-lesioned rat model of Parkinson’s disease
Manfred Gerlach
Gerd D. Bartoszyk
Maarten van den Buuse
OriginalPaper 21 January 2011 Pages: 1733 - 1742